ClinicalTrialExchange
  • Home
  • For Patients
  • For Professionals
  • About
  • Contact

Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Burning Mouth Syndrome

  • Inflammatory Markers in Saliva of Patients With Burning Mouth Syndrome
  • Caffeine vs. ALA in BMS Treatment. (BMS: Burning Mouth Syndrome. ALA: Alpha-Lipoic Acid.)
  • Effect of Treatments on Pain and Quality of Life in Individual With Burning Mouth Syndrome
  • Impact of Diazepam 1% Oral Gel Efficacy in Burning Mouth Syndrome
  • Impact of Alpha Lipoic Acid Efficacy in Burning Mouth Syndrome
  • Burning Mouth Syndrome - New Diagnostic Criteria and Treatment
  • Evaluation of the Effectiveness of the Selected Method of Treatment of Primary Burning Mouth Syndrome
  • Head Yuanshi Dian Therapy in Burning Mouth Syndrome
  • Low Level Laser Therapy Plus Topical Clonazepam Treatment to Burning Mouth Symdrome
  • Treatment of Burning Mouth Syndrome With Integration of Traditional Chinese Medicine and Western Medicine
  • The Efficacy of Melatonin in the Burning Mouth Syndrome
  • Botulinum Toxin in Burning Mouth Syndrome
  • Effectiveness of Mucolox® and Clonazepam in Treatment of Burning Mouth Syndrome
  • Acupuncture Versus Clonazepam in Burning Mouth Syndrome
  • The Role of Xerostomia in Burning Mouth Syndrome: Case - Control Study
  • Efficacy of Nalbuphine and Naloxone Administered as Nose Sprays in the Treatment of Orofacial Pain
  • Thalidomide to Treat Oral Lesions in HIV-Infected Patients
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies

Clinical Trials data from clinicaltrials.gov

Powered by DrugPatentWatch.

  • About
  • Contact
  • Follow ClinicalTrialsExchange:

      ClinicalTrialsExchange Linkedin Group